Factors associated with viral hepatitis type A in Bahia in the year 2014
DOI:
https://doi.org/10.15448/1983-652X.2017.3.24886Keywords:
communicable diseases, hepatitis A, risk factors, diseases notification.Abstract
Introduction: Hepatitis A is an infectious disease that reflects the health conditions of the population and should therefore be in constant monitoring.
Objective: To analyze factors associated with cases of hepatitis A reported in the Notifiable Diseases Information System (SINAN) in the State of Bahia, in the year 2014. The prevalence of this disease was estimated, pointing its relationship with the sociodemographic characteristics and identifying the main sources of associated infections.
Materials and Methods: This is an epidemiological cross-sectional study of exploratory character whose locus was the State of Bahia. All cases of viral hepatitis reported in SINAN in the year 2014 were included in the study. A bivariate and univariate descriptive analysis was realized.
Results: The prevalence of viral hepatitis type A was estimated to be 29.9%. The variables associated with hepatitis A were complete and incomplete elementary education, the age group under 19, the sources of home infection, person to person and contaminated food or water; hemodialysis; to be non-vaccinated for hepatitis A, to present anti-HBs serology reactant and inconclusive and to present anti-HCV serology inconclusive and unreacted.
Conclusion: In conclusion, hepatitis A was associated with sociodemographic characteristics, both individual and clinical. This requires actions and strategies that promote better hygiene and proper handling of food and water, in addition to providing a safe and clean water, control food and mass vaccination of vulnerable individuals by means of campaigns and guidance in daily consultations with health professionals.
References
Braga RCC, Valencia LIO, Medronho RA, Escoteguy CC. Estimativa de áreas de risco para hepatite A. Cad Saúde Pública. 2008;24(8): 1743-52. https://doi.org/10.1590/S0102-311X2008000800003
Silva PC, Vitral CL, Barcellos C, Kawa H, Gracie R, Rosa MLG. Hepatite A no município do Rio de Janeiro, Brasil: padrão epidemiológico e associação das variáveis sócio-ambientais. Vinculando dados do SINAN aos do Censo Demográfico. Cad Saúde Pública. 2007;23(7):1553-64. https://doi.org/10.1590/S0102-311X2007000700006
Medronho RA, Valencia LIO, Fortes BPMD, Braga RCC, Ribeiro SV. Análise espacial da soroprevalência da hepatite A em crianças de uma região carente de Duque de Caxias, RJ, Brasil. Rev Bras Epidemiol. 2003;6(4):328-34. https://doi.org/10.1590/S1415-790X2003000400007
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais. Bol Epidemiol Hepatites Virais [periódico online]. 2015 [capturado 2016 Maio 25];4(1). Disponível em: http://www.aids.gov.br/sites/default/files/anexos/publicacao/2015/58210/_p_boletim_hepatites_final_web_pdf_p__16377.pdf
Clemens SAC, Fonseca JC, Azevedo T, Cavalcanti A, Silveira T, Castilho, Clemens R. Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil. Rev Soc Bras Med Trop. 2000; 33(1):1-10. https://doi.org/10.1590/S0037-86822000000100001
Instituto Brasileiro de Geografia e Estatística. Cidades@ [Internet]: Bahia. 2016 [capturado 2016 Maio 25]. Disponível em: http://cidades.ibge.gov.br/xtras/uf.php?coduf=29
Gomes MAC, Ferreira ASP, Silva AAM, Souza ER. Hepatite A: soroprevalência e fatores associados em escolares de São Luís (MA), Brasil. Rev Bras Epidemiol. 2011;14 (4):548-55. https://doi.org/10.1590/S1415-790X2011000400002
Araujo AC, Mayvane A, Gonçalves ICM. Perfil epidemiológico das hepatites virais no estado de Pernambuco no período de 2002 a 2006 [monografia]. Recife: Fiocruz; 2008.
Ferreira CT, Taniguchi ANR, Vieira SM, Lima JP, Silveira TR. Prevalência do anticorpo da hepatite A em crianças e adolescentes com hepatopatia crônica. J Pediatr (Rio J). 2002;78(6):503-8. https://doi.org/10.1590/S0021-75572002000600011
Leão JR, Pace FHL, Chebli JMF. Infecção pelo vírus da hepatite C em pacientes em hemodiálise: prevalência e fatores de risco. Arq Gastroenterol. 2010;47(1):28-34. https://doi.org/10.1590/S0004-28032010000100006
Ferreira CT, Silveira TR. Viral hepatitis prevention by immunization. J Pediatr (Rio J). 2006;82(3 Suppl):S55-66. https://doi.org/10.1590/S0021-75572006000400007
De Soárez PC, Sartori AMC, Santos A, Itria A, Novaes HMD, Martelli CMT. Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil. Cad Saúde Pública 2012;28(2):211-28. https://doi.org/10.1590/S0102-11X2012000200002
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Hepatites virais [Internet]: o Brasil está atento. 3ª ed. Brasília: Ministério da Saúde; 2008 [capturado 2016 Maio 31]. Disponível em: http://bvsms. saude.gov.br/bvs/publicacoes/hepatites_virais_brasil_atento_3ed.pdf
Downloads
Published
Issue
Section
License
COPYRIGHT
The submission of originals to Ciência & Saúde implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Ciência & Saúde as the site of original publication.
CREATIVE COMMONS LICENSE
As this journal is open access, the articles are allowed free use in scientific and educational applications, with citation of the source.
According to the type of Creative Commons License (CC-BY 4.0) adopted by Ciência & Saúde , the user must respect the requirements below.
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
However, only under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests Ciência & Saúde endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
For more details on the Creative Commons license, please follow the link in the footer of this website.
